盤中異動 | 阿裏健康盤中下跌8%,報於7.81港元
2021年11月24日13時4分,阿裏健康(HK00241)盤中下跌8%,報於7.81港元,成交額達3.44億港元,換手率達到0.31%。
11月20日訊,市場監管總局根據《中華人民共和國反壟斷法》對43宗未依法申報違法實施經營者集中案件立案調查,並根據《中華人民共和國反壟斷法》第48條、49條對涉案企業作出行政處罰,包括50萬元罰款,涉案公司包括騰訊(00700.HK)、阿裏巴巴(09988.HK)、京東(09618.HK)及阿裏健康(00241.HK)等。
11月24日,小摩:削阿裏健康(00241)目標價69%至9港元,評級降至“中性”。11月16日,國信證券:予京東健康(06618)“增持”評級,價值區間86.17-106.2港元。11月10日,高盛:維持阿裏巴巴-SW(09988)“買入”評級,目標價245港元。
最新的財務數據顯示,公司於2021年1季度,營業收入155.18億人民幣,淨利潤3.43億人民幣;營業收入同比增加61.71%,毛利潤同比增加61.85%,淨利潤同比增加2283.23%。
盈立趨勢長盈模型最近一次交易信號,2021年11月19日出現觀望信號,觸發價格爲8.98港元(信號僅供參考)。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.